Increased basal myocardial perfusion in patients with chronic kidney disease without symptomatic coronary artery disease

Nephrology Dialysis Transplantation

Volumn 24, Issue 9, 2009, Pages 2773-2779

  Koivuviita, Niina ^a   Tertti, Risto ^a   Järvisalo, Mikko ^a   Pietilä, Mikko ^a   Hannukainen, Jarna ^b   Sundell, Jan ^b   Nuutila, Pirjo ^b   Knuuti, Juhani ^b   Metsärinne, Kaj ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b TURKU PET CENTRE   (Finland)

Author keywords

CKD; Imaging; Myocardial perfusion

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DIURETIC AGENT;

AGED; ARTICLE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIABETES MELLITUS; DISEASE MARKER; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; FEMALE; GLOMERULUS FILTRATION RATE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HUMAN; HYPEREMIA; HYPERTENSION; KIDNEY FAILURE; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; ENDOTHELIUM, VASCULAR; FEMALE; HEART; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MICROCIRCULATION; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; POSITRON-EMISSION TOMOGRAPHY; REGIONAL BLOOD FLOW; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; VASCULAR RESISTANCE;

EID: 69249083960     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp175     Document Type: Article

References (53)

1. Parfrey P, Foley R. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999; 10: 1606-1615
2. Shulman N, Ford C, Hall W et al. The Hypertension Detection and Follow-up Program Cooperative Group. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. Hypertension 1989; 13: I80-I93
3. Shlipak M, Sarnak M, Katz R et al. Cystatin C and the risk of death and cardiovascular events among elderly persons.NEngl J Med 2005; 352: 2049-2060
4. Henry R, Kostense P, Bos G et al. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study. Kidney Int 2002; 62: 1402-1407
5. Go A, Chertow G, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
6. Ansari A, Kaupke C, Vaziri N et al. Cardiac pathology in patients with end-stage renal disease maintained on hemodialysis. Int J Artif Organs 1993; 16: 31-36
7. Khalique O, Aronow W, Ahn C et al. Relation of moderate or severe reduction in glomerular filtration rate to number of coronary arteries narrowed >50% in patients undergoing coronary angiography for suspected coronary artery disease. Am J Cardiol 2007; 100: 415-416
8. Amann K, Wanner C, Ritz E. Cross-talk between the kidney and the cardiovascular system. J Am Soc Nephrol 2006; 17: 2112-2119
9. Sarnak M, Levey A. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 2000; 35: S117-S131
10. Muntner P, Hamm L, Kusek J et al. The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med 2004; 140: 9-17
11. Pannier B, Guerin A, Marchais S et al. Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease. Kidney Int 2000; 57: 1091-1099
12. Yilmaz M, Saglam M, Caglar K et al. The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine. Am J Kidney Dis 2006; 47: 42-50
13. Kanatsuka H, Lamping K, Eastham C et al. Comparison of the effects of increased myocardial oxygen consumption and adenosine on the coronary microvascular resistance. Circ Res 1989; 65: 1296-1305
14. Buus N, Bøttcher M, Hermansen F et al. Influence of nitric oxide synthase and adrenergic inhibition on adenosine-induced myocardial hyperemia. Circulation 2001; 104: 2305-2310
15. Leipert B, Becker B, Gerlach E. Different endothelial mechanisms involved in coronary responses to known vasodilators. Am J Physiol1992; 262: H1676-H1683
16. Mayhan W. Endothelium-dependent responses of cerebral arterioles to adenosine 5-diphosphate. J Vasc Res 1992; 29: 353-358
17. Levey A, Bosch J, Lewis J et al. Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130: 461-470
18. Pitk̈anen O, Raitakari O, Niinikoski H et al. Coronary flow reserve is impaired in young men with familial hypercholesterolemia. J Am Coll Cardiol 1996; 28: 1705-1711
19. Iida H, Rhodes C, de Silva R et al. Use of the left ventricular timeactivity curve as a noninvasive input function in dynamic oxygen-15- water positron emission tomography. J Nucl Med 1992; 33: 1669- 1677
20. Iida H, Takahashi A, Tamura Y et al.Myocardial blood flow: comparison of oxygen-15-water bolus injection, slow infusion and oxygen- 15-carbon dioxide slow inhalation. J Nucl Med 1995; 36: 78-85
21. J̈arvisalo M, Jartti L, Toikka J et al. Noninvasive assessment of brachial artery endothelial function with digital ultrasound and 13- MHz scanning frequency: feasibility of measuring the true inner luminal diameter using the intima-lumen interface. Ultrasound Med Biol 2000; 26: 1257-1260
22. Goodman W, Goldin J, Kuizon B et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478-1483
23. Khalique O, Aronow W, Ahn C et al. Relation of moderate or severe reduction in glomerular filtration rate to number of coronary arteries narrowed >50-1074451856n patients undergoing coronary angiography for suspected coronary artery disease. Am J Cardiol 2007; 100: 415-416
24. Oh J, Wunsch R, Turzer M et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 2002; 106: 100-105
25. Chade A, Brosh D, Higano S et al. Mild renal insufficiency is associated with reduced coronary flow in patients with non-obstructive coronary artery disease. Kidney Int 2006; 69: 266-271
26. Ragosta M, Samady H, Isaacs R et al. Coronary flow reserve abnormalities in patients with diabetes mellitus who have end-stage renal disease and normal epicardial coronary arteries. Am Heart J 2004; 147: 1017-1023
27. Tok D, Gullu H, Erdogan D et al. Impaired coronary flow reserve in hemodialysis patients: a transthoracic Doppler echocardiographic study. Nephron Clin Pract 2005; 101: c200-c206
28. McIntyre C, Burton J, Selby N et al. Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol 2008; 3: 19-26
29. Morita K, Tsukamoto T, NayaMet al. Smoking cessation normalizes coronary endothelial vasomotor response assessed with 15O-water and PET in healthy young smokers. J Nucl Med 2006; 47: 1914- 1920
30. LaineH,RaitakariO,NiinikoskiHet al. Early impairment of coronary flow reserve in young men with borderline hypertension. J Am Coll Cardiol 1998; 32: 147-153
31. Parodi O, Neglia D, Sambuceti G et al. Regional myocardial blood flow and coronary reserve in hypertensive patients. The effect of therapy. Drugs 1992; 44(Suppl 1): 48-55
32. Akinboboye O, Chou R, Bergmann S. Augmentation of myocardial blood flow in hypertensive heart disease by angiotensin antagonists: a comparison of lisinopril and losartan. J Am Coll Cardiol 2002; 40: 703-709
33. Motz W, Strauer B. Improvement of coronary flow reserve after longterm therapy with enalapril. Hypertension 1996; 27: 1031-1038
34. Parodi O, Neglia D, Palombo C et al. Comparative effects of enalapril and verapamil on myocardial blood flow in systemic hypertension. Circulation 1997; 96: 864-873
35. Naya M, Tsukamoto T, Morita K et al. Olmesartan, but not amlodipine, improves endothelium-dependent coronary dilation in hypertensive patients. J Am Coll Cardiol 2007; 50: 1144-1149
36. Higuchi T, Abletshauser C, Nekolla S et al. Effect of the angiotensin receptor blocker Valsartan on coronary microvascular flow reserve in moderately hypertensive patients with stable coronary artery disease. Microcirculation 2007; 14: 805-812
37. Buus N, Bøttcher M, Jørgensen C et al. Myocardial perfusion during long-term angiotensin-converting enzyme inhibition or beta-blockade in patients with essential hypertension. Hypertension 2004; 44: 465- 470
38. Uren N, Camici P, Melin J et al. Effect of aging on myocardial perfusion reserve. J Nucl Med 1995; 36: 2032-2036
39. Antony I, Nitenberg A, Foult J et al. Coronary vasodilator reserve in untreated and treated hypertensive patients with and without left ventricular hypertrophy. J Am Coll Cardiol 1993; 22: 514-520
40. Opherk D, Mall G, Zebe H et al. Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries. Circulation 1984; 69: 1-7
41. Treasure C, Klein J, Vita J et al. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation 1993; 87: 86-93
42. Amann K, Rychl'Ik I, Miltenberger-Milteny G et al. Left ventricular hypertrophy in renal failure. Kidney Int Suppl 1998; 68: S78-S85
43. Foley R, Parfrey P, Harnett J et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int1995; 47: 186-192
44. Raine A, Margreiter R, Brunner F et al. Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant 1992; 7(Suppl 2): 7-35
45. Uren N, Melin J, De Bruyne B et al. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med1994; 330: 1782-1788
46. Sundell J, Laine H, Luotolahti M et al. Increased coronary vascular resistance cannot be reduced by inhibiting sympathetic overactivity in hypertension. J Vasc Res 2002; 39: 456-462
47. Abendschein D, Fewell J, Carlson C et al. Myocardial blood flow during acute isovolumic anemia and treadmill exercise in dogs. J Appl Physiol 1982; 53: 203-206
48. Endemann D, Schiffrin E. Endothelial dysfunction. J Am Soc Nephrol2004; 15: 1983-1992
49. Suwaidi J, Hamasaki S, Higano S et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000; 101: 948-954
50. Heitzer T, Schlinzig T, Krohn K et al. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001; 104: 2673-2678
51. Landmesser U, Hornig B, Drexler H. Endothelial function: a critical determinant in atherosclerosis? Circulation 2004; 109: II27-II33
52. Yilmaz M, Saglam M, Carrero J et al. Serum visfatin concentration and endothelial dysfunction in chronic kidney disease. Nephrol Dial Transplant 2008; 23: 959-965
53. Olsen M, Wachtell K, Meyer C et al. Association between vascular dysfunction and reduced myocardial flow reserve in patients with hypertension: a LIFE substudy. J Hum Hypertens 2004; 18: 445- 452